U.S. Water Utilities Stock News

NYSE:CNA
NYSE:CNAInsurance

How Investors May Respond To CNA Financial (CNA) Earnings Jump, Dividend Hike, And Special Payout

CNA Financial Corporation recently reported its fourth-quarter and full-year 2025 results, showing revenue of US$3,828 million for the quarter and US$14.99 billion for the year, with net income rising to US$302 million for the quarter and US$1.28 billion for the year. Alongside these stronger earnings, CNA Financial also announced a 4% increase in its regular quarterly dividend to US$0.48 per share and a US$2.00 per-share special dividend, underscoring a focus on returning cash to...
NasdaqGS:RRR
NasdaqGS:RRRHospitality

Does Special Dividend And Vegas Outperformance Shift The Bull Case For Red Rock Resorts (RRR)?

Red Rock Resorts has already reported its fourth-quarter and full-year 2025 results, showing higher revenue but slightly lower quarterly net income, and its board declared a US$1.00 per Class A share special cash dividend payable on February 27, 2026 to stockholders of record on February 20, 2026. Alongside these results, the company highlighted record fourth-quarter gaming performance in Las Vegas and outlined expansion projects and active capital allocation, underscoring management’s focus...
NYSE:GTY
NYSE:GTYRetail REITs

Getty’s US$129.9 Million Equity Raise And Dividend Reaffirmation Might Change The Case For Investing In GTY

In February 2026, Getty Realty Corp. completed a follow-on equity offering of 4,000,000 common shares at US$32.48 per share, raising about US$129.92 million through forward sale agreements with JPMorgan Chase Bank and Wells Fargo Bank to fund acquisitions, debt repayment, and general corporate purposes. This fresh equity capital sits alongside recently reported full-year 2025 results showing higher revenue and net income year on year, and a reaffirmed quarterly dividend of US$0.485 per...
NYSE:SPG
NYSE:SPGRetail REITs

How Investors May Respond To Simon Property Group (SPG) CEO’s Klépierre Exit And Boston Luxury Redevelopment

Simon Property Group recently announced that CEO David Simon resigned from the Supervisory Board of European retail real estate company Klépierre S.A. on February 19, 2026, while also advancing a major luxury-focused redevelopment of the former Neiman Marcus space at Copley Place in Boston. Together, these developments highlight Simon’s evolving approach to European governance and its continued emphasis on remixing premier properties to attract high-end retailers and experiential dining...
NYSE:BHC
NYSE:BHCPharmaceuticals

The Bull Case For Bausch Health (BHC) Could Change Following Mixed 2025 Results And 2026 Outlook Guidance

In February 2026, Bausch Health Companies reported fourth-quarter 2025 revenue of US$2,796 million and a net loss of US$112 million, alongside full-year 2025 revenue of US$10.27 billion, net income of US$157 million, and a US$145 million goodwill impairment, while also issuing 2026 revenue guidance of US$10.63–US$10.88 billion. A day later, the company and its OraPharma dental unit marked the 25th anniversary of ARESTIN, currently the only FDA-approved locally applied antibiotic adjunct for...
NYSE:FCPT
NYSE:FCPTSpecialized REITs

How Investors May Respond To Four Corners Property Trust (FCPT) 2025 Revenue Growth Amid Flat EPS

In February 2026, Four Corners Property Trust reported its fourth-quarter and full-year 2025 results, with quarterly revenue of US$75.67 million and net income of US$29.44 million, and full-year revenue of US$294.13 million and net income of US$112.36 million. An interesting takeaway is that while full-year revenue and net income increased compared to the prior year, basic and diluted earnings per share from continuing operations only edged up slightly to US$1.09, highlighting the impact of...
NYSE:UVV
NYSE:UVVTobacco

Universal (UVV) Valuation Check After Softer Earnings And Paused Share Buybacks

Universal (UVV) is back in focus after reporting third quarter and nine month results to December 31, 2025, showing lower sales and net income year on year, with no share repurchases completed. See our latest analysis for Universal. Universal’s recent earnings softness sits against a relatively steady share price, with a 90 day share price return of 3.9% and a 1 year total shareholder return of 7.26%. This suggests modest but ongoing momentum despite weaker quarterly results and inactive...
NasdaqGS:REG
NasdaqGS:REGRetail REITs

How Regency Centers’ Expanded Shelf Registration Could Shape Financing Flexibility for REG Investors

In February 2026, Regency Centers Corporation filed an omnibus shelf registration that covers common and preferred stock, depositary shares, warrants, purchase contracts, units, and debt securities of Regency Centers, L.P., giving it the legal framework to issue a wide range of securities as needed. This broad shelf registration expands Regency Centers’ optionality for future financing or corporate actions, which investors often watch closely for signals about potential development,...
NYSE:SW
NYSE:SWPackaging

Does Smurfit Westrock (SW) Closing Quebec Capacity Reveal a Deeper Shift in Portfolio Strategy?

Smurfit Westrock Plc has reported its fourth-quarter and full-year 2025 results, with quarterly sales edging up to US$7,580 million while net income fell to US$97 million, and full-year sales rising to US$31.18 billion alongside net income of US$699 million. Alongside these results, the company moved to close a paper machine and related extrusion facility in Quebec, signaling an effort to streamline its solid bleached sulfate portfolio and sharpen the competitiveness of its paperboard...
NYSE:FCX
NYSE:FCXMetals and Mining

How Investors May Respond To Freeport-McMoRan (FCX) Securing Long-Term Grasberg Rights With Diluted Indonesian Stake

In February 2026, Freeport-McMoRan announced a Memorandum of Understanding with the Indonesian government to extend PT Freeport Indonesia’s Grasberg operating rights for the life of the resource, while committing to higher community support, increased exploration, and a future 12% ownership transfer to government interests at no cost in 2041. This framework reduces regulatory uncertainty around one of Freeport’s most important assets, but also locks in a lower long-term stake in its...
NasdaqGS:CNDT
NasdaqGS:CNDTProfessional Services

Assessing Conduent (CNDT) Valuation After Insider Buying And EBITDA Margin Progress

Why insiders are buying Conduent stock after recent EBITDA progress Recent insider share purchases at Conduent (CNDT), including buying by the CEO and a director, have drawn attention as the company reports higher full year 2025 adjusted EBITDA and improved margins despite lower revenue. See our latest analysis for Conduent. The insider buying comes after a sharp move in the 1 day share price return of 11.19% and a 7 day gain of 3.58%, although the 1 year total shareholder return of 57.6% and...
NasdaqGS:CAI
NasdaqGS:CAIBiotechs

A Look At Caris Life Sciences (CAI) Valuation After Recent Share Price Weakness

Caris Life Sciences: Event Context and Recent Share Performance Caris Life Sciences (CAI) has drawn investor attention recently as its share price has moved from a last close of US$19.53 while posting negative returns over the past week, month, and past 3 months. See our latest analysis for Caris Life Sciences. The recent 1 day share price return of a 6.33% decline, alongside a 30 day share price return of a 21.88% decline and year to date share price return of a 27.61% decline, suggests...
NYSE:SFL
NYSE:SFLOil and Gas

Does SFL’s Maintained Dividend Amid Net Losses Change The Bull Case For SFL (SFL)?

SFL Corporation Ltd. declared a quarterly cash dividend of US$0.20 per share, paid on or around March 30, 2026, to shareholders of record as of March 12, 2026, and also reported fourth-quarter 2025 revenue of US$175.51 million alongside a net loss of US$4.65 million. Despite reporting a full-year 2025 net loss of US$26.43 million, SFL sustained its US$0.20 dividend for an 88th consecutive payout, underlining management’s emphasis on ongoing cash returns. We will now examine how SFL’s...
NasdaqGS:ONB
NasdaqGS:ONBBanks

Is Board Downsizing And A Higher Dividend Altering The Investment Case For Old National Bancorp (ONB)?

Old National Bancorp recently announced that four directors, including long-serving members reaching the age limit, will retire at the May 2026 annual meeting, while the board has amended its bylaws to allow flexible board sizing and plans to shrink from 16 to 12 members. At the same time, the company raised its quarterly common dividend by 3.6% to US$0.145 per share and affirmed preferred dividends, underscoring an emphasis on capital returns alongside governance changes and ongoing...
NasdaqGS:AEIS
NasdaqGS:AEISElectronic

Assessing Advanced Energy Industries (AEIS) Valuation After Earnings Beat Guidance Upgrades Buybacks And Acquisition Plans

Advanced Energy Industries (AEIS) just wrapped up a busy set of updates, combining its fourth quarter and full year 2025 results with fresh first quarter 2026 guidance, ongoing buybacks, and acquisition plans that are drawing investor attention. See our latest analysis for Advanced Energy Industries. The earnings beat, active buybacks and management's focus on acquisitions appear to be feeding into strong momentum. A 30 day share price return of 26.33% and a 1 year total shareholder return of...
NasdaqGS:CHEF
NasdaqGS:CHEFConsumer Retailing

The Bull Case For Chefs' Warehouse (CHEF) Could Change Following Strong Q4 Beat And Cautious M&A Shift

In February 2026, The Chefs’ Warehouse reported fourth-quarter 2025 sales of US$1,142.56 million, with full-year sales reaching US$4.15 billion and net income of US$72.36 million, while management highlighted strong demand in upscale-casual and higher-end dining channels. Executives also indicated they are actively evaluating accretive, low-risk acquisitions that could complement existing territories and enhance organic growth, while carefully weighing these options against potential share...
NYSE:RL
NYSE:RLLuxury

Upgraded 2026 Revenue Outlook Might Change The Case For Investing In Ralph Lauren (RL)

Earlier in February 2026, Ralph Lauren reported a strong fiscal Q3 holiday quarter, with double-digit revenue growth and demand holding up across regions, and management lifted its full-year 2026 constant-currency revenue outlook to high-single to low-double digit growth. These results have reinforced confidence in Ralph Lauren’s ability to sustain its premium positioning while capturing growth through brand strength, product mix and broader geographic reach. We’ll now explore how this...
NasdaqGS:APLS
NasdaqGS:APLSBiotechs

Did Cautious 2026 Earnings Forecasts Just Reframe Apellis Pharmaceuticals’ (APLS) Kidney and Eye Disease Story?

In the days leading up to its 24 February 2026 earnings release, Apellis Pharmaceuticals faced expectations of a year-over-year decline in quarterly earnings and revenue, alongside a negative Earnings ESP of 3.07% and increasingly cautious analyst projections. This shift in sentiment, driven by concerns over weaker near-term performance, highlights how quickly earnings expectations can reshape perceptions of Apellis’ long-term prospects. Now, we’ll explore how this weaker earnings outlook...
NasdaqCM:CELC
NasdaqCM:CELCBiotechs

Is Celcuity’s (CELC) New Board Appointment a Turning Point for Its Commercial Strategy?

Celcuity Inc. recently appointed Charles (Chip) R. Romp, a veteran oncology-focused pharmaceutical executive and current CEO of Secura Bio, to its Board of Directors, adding more than 25 years of commercial and sales leadership experience to the company. Romp’s track record helping build commercial franchises for oncology drugs at Seagen and Genentech adds board-level insight that aligns directly with Celcuity’s focus on bringing targeted cancer therapies to market. We’ll now look at how...
NasdaqGS:QURE
NasdaqGS:QUREBiotechs

Evaluating uniQure (QURE) After New Class Action Allegations Over AMT-130 FDA Disclosures

Why the new class action matters for uniQure investors Kessler Topaz Meltzer & Check has filed a securities fraud class action against uniQure (NasdaqGS:QURE), alleging misleading statements about FDA alignment and timelines for AMT-130, its Huntington’s disease gene therapy program. See our latest analysis for uniQure. uniQure’s latest share price of US$23.43 comes after a 7 day share price return of 14.29%. However, the 90 day share price return of a 15.66% decline and 5 year total...
NasdaqGS:METC
NasdaqGS:METCMetals and Mining

A Look At Ramaco Resources (METC) Valuation After Recent Share Price Pullback

Ramaco Resources (METC) has been drawing attention after a sharp decline in its share price over the past month, even as its past 3 months return, one year total return, and longer term performance figures remain positive. See our latest analysis for Ramaco Resources. The recent 40.26% 1 month share price decline to US$16.56 sits against a much stronger backdrop, with a 1 year total shareholder return of 73.74% and multi year total shareholder returns still firmly positive. This suggests...
NasdaqGS:LIVN
NasdaqGS:LIVNMedical Equipment

Orrum Data Partnership Might Change The Case For Investing In LivaNova’s Digital Strategy (LIVN)

Orrum Clinical Analytics recently announced a partnership with LivaNova USA Inc. to link LivaNova’s Essenz Perfusion System with Orrum’s CORE Insights platform, enabling automatic transfer of perfusion case data for post-operative analysis and peer benchmarking. By extending Essenz data into a secure analytics environment that supports evidence-based performance improvement, the collaboration could strengthen LivaNova’s positioning in data-driven cardiopulmonary care and potentially appeal...
NYSE:OPLN
NYSE:OPLNCommercial Services

How OPENLANE’s 2026 Profit Outlook Versus 2025 Loss Per Share At OPENLANE (OPLN) Has Changed Its Investment Story

In February 2026, OPENLANE, Inc. reported full-year 2025 results showing revenue of US$1.93 billion and net income of US$177.7 million, while also recording a basic and diluted loss per share of US$0.96 from continuing operations. The company also issued 2026 guidance calling for income of US$130 million to US$147 million and diluted net income per share of US$0.95 to US$1.09, sharpening investor focus on how its mix of continuing and discontinued operations affects reported...
NYSE:HIG
NYSE:HIGInsurance

Assessing Hartford Insurance Group (HIG) Valuation After Recent Share Price Momentum

Event context and recent performance Hartford Insurance Group (HIG) has drawn fresh investor attention after a recent price move, with the stock closing at $142.19. That sits alongside a 10.6% return over the past month and 4.1% over the past 3 months. See our latest analysis for Hartford Insurance Group. Zooming out, Hartford Insurance Group’s recent 1 day and 1 month share price gains sit against a year to date share price return of 3.7%, while its 1 year total shareholder return is 29.8%...